Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantationAtsushi Maema, Masatoshi Makuuchi, Hiroshi Imamura et al.|Transplantation|2002Cited by 82
A phase 1/2 trial of ORIN1001, a first-in-class IRE1 inhibitor, in patients with advanced solid tumors.Nashat Gabrail, Ai‐Min Hui, Erika Hamilton et al.|Journal of Clinical Oncology|2021Cited by 25
Results of a Phase 1 Dose-Escalation Study of Once-Weekly MLN9708, an Investigational Proteasome Inhibitor, in Patients with Relapsed/Refractory LymphomaSarit Assouline, Peter Martin, Julie Chang et al.|Blood|2012Cited by 8
A multicenter, open-label, phase I/II study of FN-1501 in patients with advanced solid tumors and acute myeloid leukemia.Raed Moh’d Taiseer Al-Rajabi, Ai‐Min Hui, Chao Li et al.|Journal of Clinical Oncology|2022Cited by 1